Point of Care Diagnostic Testing World Market to Jump to $15.9 Billion by 2018

Point of Care Diagnostic Testing World Market to Jump to $15.9 Billion by 2018 
NEW YORK, NY -- (Marketwired) -- 06/27/13 --  TriMarkPublications.com
cites in its newly published "Point of Care Diagnostic Testing World
Markets" report that the point of care diagnostic testing world
market will jump to $15.9 billion by 2018. For more information,
visit:
http://www.trimarkpublications.com/products/point-of-care-diagnostic-testing-world-markets.html. 
Point of care diagnostic testing can be categorized into ten main
modalities: blood glucose monitoring, blood gas and electrolytes,
rapid coagulation, rapid cardiac markers, substance abuse, infectious
diseases, urine strip tests, pregnancy tests, fecal occult testing
and cholesterol. The U.S. is recognized as the largest single market
for point of care testing products, valued at $3.68 billion in 2012.
The U.S. point of care market sub-segment represents an estimated
18.5% of the total U.S. market for in vitro diagnostic (IVD) goods
and services. 
The "Point of Care Diagnostic Testing World Markets" report covers: 


 
--  B-Type Natriuretic Peptide (BNP)
--  Whole-Blood Lactate
--  Creatinine
--  D-Dimer Testing
--  C-Reactive Protein (CRP)
--  Glucose Urine Testing
--  Fertility Testing
--  HIV Testing
--  Alcohol Testing
--  Substance Abuse Testing

  
The "Point of Care Diagnostic Testing World Markets" report examines
companies manufacturing point of care diagnostic testing equipment
and supplies in the world. Companies covered include: Abaxis, Abbott,
AccuBioTech, Accumetrics, AccuTech, ACON, Acrongenomics, AgaMatrix,
Aerscher, Akers, Alere, Alfa, Ani, Ark, Arkray, Atlas, Atonomics,
Audit, Augurix, Axis-Shield, Axxin, Bayer Corp., Beckman Coulter,
BioLytical, Biomerica, bioMerieux, BiOracle, Bio-Rad, BioScan,
BioSite, Calmark, Calypte, Chembio, Chempaq, Cholestech, Claros,
CompuCyte, Concateno, Diagnostics, Dexcom, Enigma, EY, Eurotrol,
Exalenz, GenBio, Genzyme, Guided, Helena, Hema, HemoCue, HemoSense,
Instrumentation Laboratory, International Technidyne, Jant, Johnson &
Johnson (LifeScan), LifeAssays, LifeSign, Medica, Medical Automation,
Mediwatch, Medix, MedMira, MELA, A. Menarini, Meretek, Meridian,
Micronics, Minimed, Mitsubishi, Nanogen, New Horizons, Nexus, Nova,
OraSure, Orion, Polymedco, Polymer, Prima, QBC, Qualigen, Quest,
Quidel, Radiometer, Response, Roche, Savyon, Selfcare, Shanghai
Ruicare, Shenzhen Fittconn, Shionogi, Siemens, Spectral, StatSure,
Step Detect, Strategic, Trinity and Vasamed. 
Detailed charts with sales forecasts and marketshare data are
included. For more information, visit:
http://www.trimarkpublications.com/products/point-of-care-diagnostic-testing-world-markets.html. 
About TriMarkPublications.com 
TriMarkPublications.com is a global leader in the biotechnology,
healthcare and life sciences market research publishing. For more
information, please visit http://www.trimarkpublications.com.  
Important Notice 
The statements contained in this news release that are
forward-looking are based on current expectations that are subject to
a number of uncertainties and risks, and actual results may differ
materially. 
Contact 
TriMarkPublications.com
Media Relations
1-888-OK-TRIMARK
www.trimarkpublications.com 
 
 
Press spacebar to pause and continue. Press esc to stop.